Ebaid, N.F.; Abdelkawy, K.S.; Said, A.S.A.; Al-Ahmad, M.M.; Shehata, M.A.; Salem, H.F.; Hussein, R.R.S.
Is the Neutrophil-to-Lymphocyte Ratio a Predictive Factor of Pathological Complete Response in Egyptian Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? Medicina 2025, 61, 327.
https://doi.org/10.3390/medicina61020327
AMA Style
Ebaid NF, Abdelkawy KS, Said ASA, Al-Ahmad MM, Shehata MA, Salem HF, Hussein RRS.
Is the Neutrophil-to-Lymphocyte Ratio a Predictive Factor of Pathological Complete Response in Egyptian Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? Medicina. 2025; 61(2):327.
https://doi.org/10.3390/medicina61020327
Chicago/Turabian Style
Ebaid, Naglaa F., Khaled S. Abdelkawy, Amira S. A. Said, Mohamad M. Al-Ahmad, Mohamed A. Shehata, Heba F. Salem, and Raghda R. S. Hussein.
2025. "Is the Neutrophil-to-Lymphocyte Ratio a Predictive Factor of Pathological Complete Response in Egyptian Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?" Medicina 61, no. 2: 327.
https://doi.org/10.3390/medicina61020327
APA Style
Ebaid, N. F., Abdelkawy, K. S., Said, A. S. A., Al-Ahmad, M. M., Shehata, M. A., Salem, H. F., & Hussein, R. R. S.
(2025). Is the Neutrophil-to-Lymphocyte Ratio a Predictive Factor of Pathological Complete Response in Egyptian Breast Cancer Patients Treated with Neoadjuvant Chemotherapy? Medicina, 61(2), 327.
https://doi.org/10.3390/medicina61020327
